These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7387005)

  • 1. An abnormal lipoprotein in the serum of uremic patients maintained on chronic hemodialysis.
    Papadopoulos NM; Borer WZ; Elin RJ; Diamond LH
    Ann Intern Med; 1980 May; 92(5):634-5. PubMed ID: 7387005
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK; Pasternack A; Vänttinen T; Ehnholm C; Nikkilä EA
    Acta Med Scand; 1978; 204(3):211-8. PubMed ID: 211802
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.
    Bagdade J; Casaretto A; Albers J
    J Lab Clin Med; 1976 Jan; 87(1):38-48. PubMed ID: 173766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipoproteinemia (a remnant lipoprotein disease) in uremic patients on hemodialysis.
    Minamisono T; Wada M; Akamatsu A; Okabe M; Handa Y; Morita T; Asagami C; Naito HK; Nakamoto S; Lewis LA; Mise J
    Clin Chim Acta; 1978 Mar; 84(1-2):163-72. PubMed ID: 639300
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerosis in patients undergoing maintenance hemodialysis.
    Bagdade JD
    Kidney Int Suppl; 1975 Feb; (3):370-2. PubMed ID: 169427
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipoprotein binding and hypertriglyceridemia in chronic uremia.
    Samar RE; Moncrief JW; Decherd JF; Popovich RP
    Trans Am Soc Artif Intern Organs; 1975; 21():455-63. PubMed ID: 167492
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis.
    Cattran DC; Steiner G; Fenton SS; Wilson DR
    Trans Am Soc Artif Intern Organs; 1974; 20A():148-52. PubMed ID: 4450333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyslipidemia and accelerated atherosclerosis in chronic uremia: a probably decreasing pathology, due to nutritional studies and better dietary guidelines].
    Campanacci L; Guabnieri GF; Toigo G; Huber W; Legnani F; Moracchiello M; Tesio F; Raimondi A
    G Clin Med; 1978; 59(7-8):318-31. PubMed ID: 216602
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
    László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P
    Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258
    [No Abstract]   [Full Text] [Related]  

  • 11. Apoprotein composition of plasma lipoproteins in uremic patients on hemodialysis.
    Staprans I; Felts JM; Zacherle B
    Clin Chim Acta; 1979 Apr; 93(1):135-43. PubMed ID: 219972
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoprotein profile in dialysis and transplant patients.
    Lau YK; Woo KT; Lim CH
    Singapore Med J; 1985 Apr; 26(2):193-7. PubMed ID: 3898396
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
    Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a treatment necessity for lipid disorders of uremic patients?
    Lacour B; Roullet JB; Beyne P; Drüeke T
    Blood Purif; 1985; 3(1-3):42-51. PubMed ID: 3938287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study on hyperlipidaemia and diet in RDT patients.
    Palmo A; Boggio-Bertinet D; Balzola F; Stratta P; Triolo G; Alloatti S; Bosticardo G; Giacchino F; Pagano GF; Levis F
    Minerva Nefrol; 1982; 29(1):29-35. PubMed ID: 7048140
    [No Abstract]   [Full Text] [Related]  

  • 16. Atherosclerosis in uremia: a longitudinal study.
    Bonomini V; Feletti C; Scolari MP; Stefoni S; Vangelista A
    Am J Clin Nutr; 1980 Jul; 33(7):1493-500. PubMed ID: 6994473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial stiffness in predialysis patients with uremia.
    Shinohara K; Shoji T; Tsujimoto Y; Kimoto E; Tahara H; Koyama H; Emoto M; Ishimura E; Miki T; Tabata T; Nishizawa Y
    Kidney Int; 2004 Mar; 65(3):936-43. PubMed ID: 14871413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia.
    Shoji T; Hatsuda S; Tsuchikura S; Kimoto E; Kakiya R; Tahara H; Koyama H; Emoto M; Tabata T; Nishizawa Y
    Atherosclerosis; 2009 Dec; 207(2):579-84. PubMed ID: 19540497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cholesterol binding reserve and high density lipoprotein cholesterol in patients on maintenance hemodialysis.
    Perez GO; Hsia SL; Christakis G; Burr J
    Horm Metab Res; 1980 Sep; 12(9):449-54. PubMed ID: 7429416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.